Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6669704

Cc1ccnc(NCCCC(=O)NCC(=O)NC(CC(=O)O)c2ccccc2[N+](=O)[O-])c1.O=C(O)C(F)(F)F

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGAV P06756 12/20 0.64
ITGB6 P18564 8/20 0.64
ITGB1 P05556 1/20 0.64
ITGA5 P08648 1/20 0.64
ITGB3 P05106 11/20 0.62
ITGB5 P18084 7/20 0.62
ITGA2B P08514 4/20 0.57
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
POLB P06746 2/20 0.41
CYP26A1 O43174 1/20 0.40
CTSA P10619 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7173695 0.98 ITGAV (0.62) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL6669951 0.95 ITGAV (0.61) ITGAVITGB6ITGB1ITGA5ITGB3
Trifluoroacetic Acid SCHEMBL7175555 0.94 ITGAV (0.62) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7172069 0.93 ITGAV (0.64) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7172208 0.92 ITGAV (0.63) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7172197 0.92 ITGAV (0.63) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7172214 0.92 ITGAV (0.63) ITGAVITGB6ITGB1ITGA5ITGB3
Trifluoroacetic Acid SCHEMBL7173594 0.90 ITGAV (0.58) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7171785 0.89 ITGAV (0.55) ITGAVITGB6ITGB1ITGA5ITGB3
SCHEMBL7175562 0.89 ITGAV (0.62) ITGAVITGB6ITGB1ITGA5ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1153014-B1 BETA-ALANINE DERIVATIVES MERCK PATENT GMBH (DE) 2004-09-22 EP disclosed
US-6576637-B1 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, MERCK PATENT GMBH (DE) 2003-06-10 US disclosed
EP-1153014-A2 BETA-ALANINE DERIVATIVES MERCK PATENT GmbH (DE) 2001-11-14 EP disclosed
WO-2000048996-A2 β-ALANINE DERIVATIVES MERCK PATENT GMBH (DE) 2000-08-24 WO disclosed